Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
14/10/2008	22h30	PR Newswire (US)	Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)	NASDAQ:INSM
14/10/2008	14h05	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:INSM	Insmed Inc
14/10/2008	14h00	PR Newswire (US)	Insmed to Seek Shareholder Approval for Reverse Split	NASDAQ:INSM
23/09/2008	15h48	PR Newswire (US)	Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature	NASDAQ:INSM	Insmed Inc
15/09/2008	14h00	PR Newswire (US)	Insmed to Present at Biosimilars 2008 Conference	NASDAQ:INSM	Insmed Inc
04/09/2008	14h00	PR Newswire (US)	Insmed to Present at BioPharm Asia 2008 Conference	NASDAQ:INSM	Insmed Inc
03/09/2008	22h09	Edgar (US Regulatory)	Insmed Inc - Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
03/09/2008	14h00	PR Newswire (US)	NASDAQ Hearing Panel Grants Insmed Request for Continued Listing on the NASDAQ Stock Market	NASDAQ:INSM	Insmed Inc
08/08/2008	22h06	Edgar (US Regulatory)	Insmed Inc - Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
08/08/2008	14h00	PR Newswire (US)	Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008	NASDAQ:INSM
28/07/2008	15h20	PR Newswire (US)	BeaconEquity.com Issues Technical Trade Alerts on Market Movers: EPCT, INSM, AMGN, CYBS, KONG, NCOC	NASDAQ:INSM	Insmed Inc
28/07/2008	14h00	PR Newswire (US)	Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development	NASDAQ:INSM	Insmed Inc
25/07/2008	14h15	PR Newswire (US)	Insmed to Host Second Quarter 2008 Conference Call	NASDAQ:INSM	Insmed Inc
25/07/2008	14h00	PR Newswire (US)	Insmed CEO to Present at Drug Discovery & Development Conference	NASDAQ:INSM	Insmed Inc
22/07/2008	14h00	PR Newswire (US)	Insmed CEO to Present at Congressional Briefing on Follow-On Biologics	NASDAQ:INSM
21/07/2008	14h00	PR Newswire (US)	Insmed Provides Update on IPLEX(TM) Programs	NASDAQ:INSM
17/07/2008	14h00	PR Newswire (US)	Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor	NASDAQ:INSM
14/07/2008	14h00	PR Newswire (US)	Insmed Retains RBC Capital Markets as Strategic Financial Advisor	NASDAQ:INSM
10/07/2008	14h00	PR Newswire (US)	Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company	NASDAQ:INSM	Insmed Inc
09/07/2008	14h00	PR Newswire (US)	Insmed to Present at Collins Stewart Fourth Annual Growth Conference	NASDAQ:INSM
20/06/2008	23h30	PR Newswire (US)	Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination	NASDAQ:INSM	Insmed Inc
02/06/2008	22h18	Edgar (US Regulatory)	Insmed Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
08/05/2008	16h22	PR Newswire (US)	/C O R R E C T I O N -- Insmed Inc./	NASDAQ:INSM	Insmed Inc
08/05/2008	13h00	PR Newswire (US)	Insmed Announces First Quarter 2008 Financial Results	NASDAQ:INSM	Insmed Inc
29/04/2008	15h00	PR Newswire (US)	Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs	NASDAQ:INSM	Insmed Inc
24/04/2008	15h00	PR Newswire (US)	Insmed to Host First Quarter 2008 Conference Call	NASDAQ:INSM
22/04/2008	15h00	PR Newswire (US)	Insmed to Present at CBI Follow-On Biologics Conference	NASDAQ:INSM	Insmed Inc
16/04/2008	15h00	PR Newswire (US)	Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)	NASDAQ:INSM	Insmed Inc
11/04/2008	22h09	Edgar (US Regulatory)	Insmed Inc - Amended Annual Report (10-K/A)	NASDAQ:INSM	Insmed Inc
10/04/2008	14h00	PR Newswire (US)	Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulator	NASDAQ:INSM	Insmed Inc